Publications

Boccia S, Sayed-Tabatabaei FA, Persiani R, Gianfagna F, et al. (2007). Polymorphisms in metabolic genes, their combination and interaction with tobacco smoke and alcohol consumption and risk of gastric cancer: a case-control study in an Italian population. BMC Cancer 7: 206. http://dx.doi.org/10.1186/1471-2407-7-206 PMid:17996038 PMCid:2194718   Cantor KP, Villanueva CM, Silverman DT, Figueroa JD, et al. (2010). Polymorphisms in GSTT1, GSTZ1, and CYP2E1, disinfection by-products, and risk of bladder cancer in Spain. Environ. Health Perspect. 118: 1545-1550. http://dx.doi.org/10.1289/ehp.1002206 PMid:20675267 PMCid:2974691   Ferlay J, Shin HR, Bray F, Forman D, et al. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 15: 2893-2917. http://dx.doi.org/10.1002/ijc.25516 PMid:21351269   Ferreira CG and Rocha JC (2004). Oncologia Molecular. Editora Atheneu, São Paulo.   Gao CM, Takezaki T, Wu JZ, Chen MB, et al. (2007). CYP2E1 RsaI polymorphism impacts on risk of colorectal cancer association with smoking and alcohol drinking. World J. Gastroenterol. 13: 5725-5730. PMid:17963298   Ginsberg G, Smolenski S, Neafsey P, Hattis D, et al. (2009). The influence of genetic polymorphisms on population variability in six xenobiotic-metabolizing enzymes. J. Toxicol. Environ. Health B Crit. Rev. 12: 307-333. http://dx.doi.org/10.1080/10937400903158318 PMid:20183525   Hayashi S, Watanabe J and Kawajiri K (1991). Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J. Biochem. 110: 559-565. PMid:1778977   INCA (2011). Instituto Nacional do Câncer. Ministério da Saúde. Available at [http://www1.inca.gov.br/estimativa/2012/]. Accessed January, 2011.   Jia WH, Pan QH, Qin HD, Xu YF, et al. (2009). A case-control and a family-based association study revealing an association between CYP2E1 polymorphisms and nasopharyngeal carcinoma risk in Cantonese. Carcinogenesis 30: 2031-2036. http://dx.doi.org/10.1093/carcin/bgp239 PMid:19805575 PMCid:2792314   Kiss I, Sandor J, Pajkos G, Bogner B, et al. (2000). Colorectal cancer risk in relation to genetic polymorphism of cytochrome P450 1A1, 2E1, and glutathione-S-transferase M1 enzymes. Anticancer Res. 20: 519-522. PMid:10769717   Knodell RG, Browne DG, Gwozdz GP, Brian WR, et al. (1991). Differential inhibition of individual human liver cytochromes P-450 by cimetidine. Gastroenterology 101: 1680-1691. PMid:1955133   Küry S, Buecher B, Robiou-du-Pont S, Scoul C, et al. (2007). Combinations of cytochrome P450 gene polymorphisms enhancing the risk for sporadic colorectal cancer related to red meat consumption. Cancer Epidemiol. Biomarkers Prev. 16: 1460-1467. http://dx.doi.org/10.1158/1055-9965.EPI-07-0236 PMid:17627011   Le-Marchand L, Donlon T, Seifried A and Wilkens LR (2002). Red meat intake, CYP2E1 genetic polymorphisms, and colorectal cancer risk. Cancer Epidemiol. Biomarkers Prev. 11: 1019-1024. PMid:12376502   Lu D, Yu X and Du Y (2011). Meta-analyses of the effect of cytochrome P450 2E1 gene polymorphism on the risk of head and neck cancer. Mol. Biol. Rep. 38: 2409-2416. http://dx.doi.org/10.1007/s11033-010-0375-9 PMid:21076874   Masuda G, Tokunaga A, Shirakawa T, Togashi A, et al. (2007). Helicobacter pylori infection, but not genetic polymorphism of CYP2E1, is highly prevalent in gastric cancer patients younger than 40 years. Gastric. Cancer 10: 98-103. http://dx.doi.org/10.1007/s10120-007-0414-y PMid:17577619   Morita M, Le ML, Kono S, Yin G, et al. (2009). Genetic polymorphisms of CYP2E1 and risk of colorectal cancer: the Fukuoka Colorectal Cancer Study. Cancer Epidemiol. Biomarkers Prev. 18: 235-241. http://dx.doi.org/10.1158/1055-9965.EPI-08-0698 PMid:19124503   Neafsey P, Ginsberg G, Hattis D, Johns DO, et al. (2009). Genetic polymorphism in CYP2E1: Population distribution of CYP2E1 activity. J. Toxicol. Environ. Health B Crit. Rev. 12: 362-388. http://dx.doi.org/10.1080/10937400903158359 PMid:20183527   Reszka E, Wasowicz W and Gromadzinska J (2006). Genetic polymorphism of xenobiotic metabolising enzymes, diet and cancer susceptibility. Br. J. Nutr. 96: 609-619. PMid:17010218   Tang K, Li Y, Zhang Z, Gu Y, et al. (2010). The PstI/RsaI and DraI polymorphisms of CYP2E1 and head and neck cancer risk: a meta-analysis based on 21 case-control studies. BMC Cancer 10: 575. http://dx.doi.org/10.1186/1471-2407-10-575 PMid:20969746 PMCid:2988025   Wang Y, Yang H, Li L, Wang H, et al. (2010). Association between CYP2E1 genetic polymorphisms and lung cancer risk: a meta-analysis. Eur. J. Cancer 46: 758-764. http://dx.doi.org/10.1016/j.ejca.2009.12.010 PMid:20031389   Zhan P, Wang J, Zhang Y, Qiu LX, et al. (2010). CYP2E1 RsaI/PstI polymorphism is associated with lung cancer risk among Asians. Lung Cancer 69: 19-25. http://dx.doi.org/10.1016/j.lungcan.2009.09.001 PMid:19796841   Zhou GW, Hu J and Li Q (2010). CYP2E1 PstI/RsaI polymorphism and colorectal cancer risk: a meta-analysis. World J. Gastroenterol. 16: 2949-2953. http://dx.doi.org/10.3748/wjg.v16.i23.2949 PMid:20556843 PMCid:2887593